CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Kintor Pharmaceutical Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Kintor Pharmaceutical Ltd
No.20 Songbei Road
Suzhou Industrial Park
Phone: +86 51262639909p:+86 51262639909 SUZHOU, JNG  215123  China Ticker: 99399939
Business Summary
Kintor Pharmaceutical Ltd is a clinical-stage new drug developer. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers dermatology (such as hair loss, acne) and tumor indications. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Chief Executive Officer TongYouzhi 60 5/16/2018 5/16/2018
Chief Financial Officer, Joint Company Secretary Ming MingCheung 46 5/12/2023 9/1/2021
Chief Technology Officer, Executive Director QunLu 57 4/14/2023 5/1/2021
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 168 (As of 12/31/2024)
Outstanding Shares: 447,499,600 (As of 12/31/2024)
Stock Exchange: HKG


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 18, 2025